Pharmaceuticals, Biotechnology and Life Sciences
In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects…
New biomarker and immune data presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual MeetingFollowing the recent presentation…
Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following…
Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration…
LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
BioTech Breakthrough Awards The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the…
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end…
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of…
– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC;…
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based…